Little Cortendo gains $11M for late-stage Cushing’s study, hatches U.S. IPO plans

John Carroll

is coming to America. Founded in Sweden, the biotech has a new CEO who's building the executive team in the Philadelphia area. And he's dropping for a listing on the Oslo exchange in favor of a IPO after raising $ 11 million in bridge financing.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS